We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
23 hedge funds and large institutions have $9.16M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
6% more capital invested
Capital invested by funds: $8.68M → $9.16M (+$488K)
4% less funds holding
Funds holding: 24 → 23 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$420K |
| 2 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$75.5K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$16.8K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.58K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.39K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| – | -$1K | -4 | Closed |
|
27
Citigroup
New York
| – | +$139 | +1 | New |
|